These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15272127)

  • 1. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis.
    Audebert HJ; Rott MM; Eck T; Haberl RL
    Stroke; 2004 Sep; 35(9):2128-33. PubMed ID: 15272127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany.
    Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL
    Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal fluid-attenuated inversion recovery hyperintensity within acute diffusion-weighted imaging lesions is associated with symptomatic intracerebral hemorrhage after thrombolysis.
    Cho AH; Kim JS; Kim SJ; Yun SC; Choi CG; Kim HR; Kwon SU; Lee DH; Kim EK; Suh DC; Kang DW
    Stroke; 2008 Dec; 39(12):3424-6. PubMed ID: 18772449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic stroke patients.
    Tiainen M; Meretoja A; Strbian D; Suvanto J; Curtze S; Lindsberg PJ; Soinne L; Tatlisumak T;
    Int J Stroke; 2013 Dec; 8(8):632-8. PubMed ID: 23590464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.
    Kremer C; Kappelin J; Perren F
    J Clin Neurosci; 2014 Oct; 21(10):1828-30. PubMed ID: 24852905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis.
    Sander K; Sander D
    Stroke; 2005 Feb; 36(2):232; author reply 232. PubMed ID: 15653578
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.
    Jauch EC; Lindsell C; Broderick J; Fagan SC; Tilley BC; Levine SR;
    Stroke; 2006 Oct; 37(10):2508-13. PubMed ID: 16960091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome.
    Smith CJ; Emsley HC; Gavin CM; Georgiou RF; Vail A; Barberan EM; del Zoppo GJ; Hallenbeck JM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
    BMC Neurol; 2004 Jan; 4():2. PubMed ID: 14725719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
    Hill MD; Rowley HA; Adler F; Eliasziw M; Furlan A; Higashida RT; Wechsler LR; Roberts HC; Dillon WP; Fischbein NJ; Firszt CM; Schulz GA; Buchan AM;
    Stroke; 2003 Aug; 34(8):1925-31. PubMed ID: 12843342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility-weighted imaging for cerebral microbleed detection in super-acute ischemic stroke patients treated with intravenous thrombolysis.
    Bai Q; Zhao Z; Sui H; Xie X; Chen J; Yang J; Zhang L
    Neurol Res; 2013 Jul; 35(6):586-93. PubMed ID: 23561793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolysis in acute ischemic stroke with intravenous recombinant tissue-type plasminogen activator].
    May Z; Kakuk I; Ováry C; Ricsóy G; Skopál J; Szegedi N; Varga D; Nagy Z
    Orv Hetil; 2002 Nov; 143(44):2479-84. PubMed ID: 12674802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in C-Reactive Protein Levels Are Associated with Neurological Change Twenty-Four Hours after Thrombolysis for Acute Ischemic Stroke.
    Gill D; Sivakumaran P; Wilding P; Love M; Veltkamp R; Kar A
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1966-9. PubMed ID: 27212272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.